<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Fetal <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> (HbF) is an established serological indicator of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, its distribution in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissues is rarely investigated </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, HbF was studied immunohistologically in different <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> characterised by high blood HbF concentrations </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Anti-HbF was immunoaffinity purified and used to study HbF immunohistochemically in the following <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>: <z:e sem="disease" ids="C0205851" disease_type="Neoplastic Process" abbrv="">germ cell tumour</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCT</z:e>), <z:e sem="disease" ids="C1135868" disease_type="Neoplastic Process" abbrv="">trophoblastic disease</z:e> (TD), <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (MM), and ovarian <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OA</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCT</z:e> a distinction was made between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> substantially without HbF positive red blood cells (F-RBC) and those with F-RBC </plain></SENT>
<SENT sid="5" pm="."><plain>Those without F-RBC were non-metastatic mature <z:hpo ids='HP_0009792'>teratomas</z:hpo> and <z:mp ids='MP_0002016'>dermoid cysts</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Those containing F-RBC were mainly embryonal <z:mp ids='MP_0002038'>carcinomas</z:mp> and metastatic <z:hpo ids='HP_0009792'>teratomas</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>HbF positive myeloid cells (F-MLC), HbF positive normoblasts (F-<z:chebi fb="28" ids="53174">NBS</z:chebi>), and F-RBC were common in the bone marrow and in the lymphoid tissues of <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and MM </plain></SENT>
<SENT sid="8" pm="."><plain>In TD, <z:mpath ids='MPATH_458'>normal</z:mpath> and nucleated F-RBC were seen in the trophoblastic villi in one case with <z:e sem="disease" ids="C0334529" disease_type="Neoplastic Process" abbrv="">incomplete molar pregnancy</z:e> (ICM) but not in other cases of ICM and <z:e sem="disease" ids="C0678213" disease_type="Neoplastic Process" abbrv="">complete molar pregnancy</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>However, F-RBC and F-MLC were seen in the decidua of both types of TD </plain></SENT>
<SENT sid="10" pm="."><plain>Generally, F-cells were observed either within blood vessels or concentrated in certain areas of the neoplastic tissue </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: HbF was evaluated as an inducible marker within different <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue blood cells </plain></SENT>
<SENT sid="12" pm="."><plain>The dual distribution of these cells-circulating in the blood or concentrated in areas of the neoplastic tissues-might reflect the two independent serological indicators of HbF: one in whole blood and the other in plasma of patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>